[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2024-2029 NAT and Immunohematology Market: Supplier Sales and Shares by Country, Emerging Assays, Companies Developing New Technologies and Products

November 2024 | | ID: 287947F52405EN
Venture Planning Group

US$ 2,850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.Contains 197 pages and 6 tables


More Publications